公司资料
Cyclerion 股价、新闻与催化剂
- 股票代码:
- CYCN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
23.52 USD (+453.41%)
收盘价
最后更新: 2026年9月8日
13.1M USD
市值
股价为何变动
目前无法获取 CYCN 的收盘价变动背景。
公司概览
业务概览
Cyclerion was a biotechnology company focused on cyclic nucleotide biology and central nervous system or vascular-related disease programs before becoming a historical ticker. Its story reflected the challenge of turning a mechanistic platform into a durable drug franchise.
所在地与行业分类
Cyclerion was headquartered in the United States and traded on NASDAQ. It sat in the development-stage biotechnology segment.
商业模式特征
The business depended on clinical validation, strategic focus, and capital efficiency. Investors historically watched whether the platform could produce differentiated medicines in a difficult field.
生物医药行业定位
Cyclerion belongs to the historical platform-biotech set. Like many early scientific names, its stock depended on data and the market's patience for development risk.
未来催化剂
- Cyclerion is now largely a legacy and closeout story, so the catalysts are any strategic or asset-disposition update rather than a live pipeline event. The market is mainly waiting for clarity on remaining value.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。